Terns Pharmaceuticals Inc (TERN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,642 | -19,051 | -9,206 | -68,819 | -6,980 |
| Depreciation Amortization | 325 | 224 | 125 | 155 | 450 |
| Income taxes - deferred | 0 | 131 | 130 | N/A | N/A |
| Accounts payable and accrued liabilities | -1,176 | -1,556 | -245 | N/A | N/A |
| Other Working Capital | 4,624 | 2,195 | 1,462 | 1,868 | 6,220 |
| Other Operating Activity | 4,447 | 1,948 | 447 | 574 | 890 |
| Operating Cash Flow | $-22,422 | $-16,109 | $-7,287 | $-66,222 | $580 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 7,277 | 7,277 | 7,277 | N/A | N/A |
| PPE Investments | -537 | -532 | -430 | -900 | -280 |
| Other Investing Activity | 0 | 0 | 0 | -2,956 | 3,990 |
| Investing Cash Flow | $6,740 | $6,745 | $6,847 | $-3,856 | $3,710 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 16,876 | 16,876 | N/A | N/A | N/A |
| Common Stock Issued | 32 | 0 | N/A | N/A | N/A |
| Other Financing Activity | -33 | -33 | -33 | 62 | 0 |
| Financing Cash Flow | $16,875 | $16,843 | $-33 | $62 | $0 |
| Exchange Rate Effect | 236 | -216 | -158 | -131 | -110 |
| Beginning Cash Position | 12,375 | 12,375 | 12,375 | 82,522 | 8,360 |
| End Cash Position | 13,804 | 19,638 | 11,744 | 12,375 | 12,540 |
| Net Cash Flow | $1,429 | $7,263 | $-631 | $-70,147 | $4,180 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,422 | -16,109 | -7,287 | -66,222 | 580 |
| Capital Expenditure | -537 | -532 | -430 | N/A | N/A |
| Free Cash Flow | -22,959 | -16,641 | -7,717 | -66,222 | 580 |